Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF
CD200, a type I membrane glycoprotein, plays an important role in prevention of inflammatory disorders, graft rejection, autoimmune diseases and spontaneous fetal loss. It also regulates tumor immunity. A truncated CD200 (CD200(tr)) resulting from alternative splicing has been identified and charact...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965252/ https://www.ncbi.nlm.nih.gov/pubmed/20558599 http://dx.doi.org/10.1093/nar/gkq554 |